Activity‐Based Functional Exercise for Disability in Systemic Sclerosis: Protocol for a Feasibility Randomised Controlled Trial

Read full text
Authors: Gabriela da Silva Santos, André Nunes Soares, GEISIELLY MARIA PORTO SOARES, Thaís Ariadne Medeiros de Lima, Juliana Fernandes, Ângela Luzia Branco Pinto Duarte, Angélica da Silva Tenório, Andrea Tavares Dantas
Cited by: 1
References: 19

Abstract

INTRODUCTION: Systemic Sclerosis (SSc) is associated with substantial disability in affected patients. Although exercise interventions for SSc have been developed, most focus on isolated body segments rather than global disability. Thus, this study aims to assess the feasibility of a functional activity-based exercise programme designed to address disability in individuals with SSc. METHODS: This feasibility study protocol is designed as a randomised controlled mixed-methods trial. It will include individuals with SSc aged 18-65 years and with a score ≥ 1 on the Scleroderma Health Assessment Questionnaire (SHAQ). Participants will be randomly allocated to either a control group, receiving an educational booklet on the disease, or an intervention group receiving the booklet plus a 10-week supervised functional exercise protocol (twice weekly). Feasibility outcomes include recruitment and retention rates, adherence, safety, and adverse events. Preliminary clinical outcomes will address disability level, physical function, fatigue, resilience, symptoms of anxiety and depression, and perceived change. Quantitative data will be analysed using descriptive and inferential statistics, while qualitative data will undergo thematic content analysis. ETHICAL APPROVAL: The study was approved by the Institutional Ethics Committee (Approval Number: 6.992.710). RESULTS: The study is in its initial phase. The reference clinic has 219 registered patients, of whom 183 (83.6%) are preliminarily eligible. Recruitment and subsequent feasibility results are ongoing. CONCLUSION: This protocol proposes an innovative and low-cost approach, whose results will support refinements for a more rigorous clinical trial, despite potential logistical and disease-related limitations.

Fields of Study & Subjects

Systemic Sclerosis and Related Diseases Inflammatory Myopathies and Dermatomyositis Multiple Sclerosis Research Studies

Publication details

Journal / source
Musculoskeletal Care
Publisher
Wiley
Volume
24
Issue
2
Pages
e70217–e70217
Publication date
30 March 2026
Language
EN